|
The Plasma Protein Therapeutics Association (PPTA) is pleased to invite you and your colleagues to attend the 2013 Plasma Protein Forum at the Hyatt Regency in Reston, Virginia. An exciting program is planned for this year’s Plasma Protein Forum, to be held Tuesday, June 11 and Wednesday, June 12.
People worldwide rely on access to plasma-derived and recombinant analog therapies to improve and save their lives, and this is an opportunity for all stakeholders to come together. Consumers, physicians, caregivers, regulators and policymakers, and industry representatives should attend. Key issues facing the industry today and in the future will be presented.
The Forum will address policies and regulations that impact consumers’ access to life-saving therapies in thought-provoking and engaging sessions. The plasma protein therapeutics community must work together to assure patient access. Our commitment to the community is steadfast and inspires new solutions to the challenges of today and tomorrow.
The 2013 Forum panel discussions include:
- 30 Years of the Orphan Drug Act
- Centering the Patients in Rare Disease Treatment: Comparing Effectiveness and Cost
- Rare Disease Profiles in Emerging Countries
- Biovigilance
- IVIG – Associated Hemolysis
There is no better opportunity to meet and network with key members of the plasma protein therapeutics industry. Let us continue to demonstrate our collective “Commitment to the Community!” Register today!
Best regards,
Julie A. Birkofer
Senior Vice President, North America
|